---
figid: PMC6505497__12035_2018_1338_Fig4_HTML
figlink: /pmc/articles/PMC6505497/figure/Fig4/
number: Fig. 4
caption: Activation of Spry2 (conserved cysteine-rich region in green) in response
  to receptor tyrosine kinase (RTK) stimulation is induced by Src kinase (Y55 phosphorylation,
  Y53 for Spry4) followed by phosphatase recruitment (PP2A) which dephosphorylates
  serines 112 and 115. This results in conformational change at the C-terminal proline-rich
  binding site for GRB2 (light blue, present in Spry2 only) that now becomes accessible
  and prevents interaction with SOS required for downstream ERK activation (interacting
  proteins indicated in light gray boxes). Other binding partners and covalent modifiers
  (listed in dark gray boxes) have been demonstrated to interact mainly with human
  Spry2. Based on sequence similarities and experimental evidence, however, many of
  them also bind Spry1 and Spry4 [, ]. Spry4 has been shown to inhibit the ERK pathway
  predominantly by interaction with SOS1, and all Sprouties may form functionally
  active hetero- and homo-oligomers through their C-terminal domains []. Src, non-receptor
  kinase; C-Cbl, Casitas b-lineage lymphoma ubiquitin E3 ligase; CIN85, Cbl-interacting
  protein of 85 kD; PLCγ, phospholipase Cγ; SIAH2, seven in absentia homolog ubiquitin
  E3 ligase; PP2A, protein phosphatase 2A; PKC, protein kinase C; Tesk1, testicular
  protein kinase 1; CK, casein kinase; DYRK1A, dual-specificity tyrosine-phosphorylation-regulated
  kinase 1A
pmcid: PMC6505497
papertitle: Sprouty2—a Novel Therapeutic Target in the Nervous System?.
reftext: Barbara Hausott, et al. Mol Neurobiol. 2019;56(6):3897-3903.
pmc_ranked_result_index: '197511'
pathway_score: 0.811663
filename: 12035_2018_1338_Fig4_HTML.jpg
figtitle: Sprouty2—a Novel Therapeutic Target in the Nervous System?.
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6505497__12035_2018_1338_Fig4_HTML.html
  '@type': Dataset
  description: Activation of Spry2 (conserved cysteine-rich region in green) in response
    to receptor tyrosine kinase (RTK) stimulation is induced by Src kinase (Y55 phosphorylation,
    Y53 for Spry4) followed by phosphatase recruitment (PP2A) which dephosphorylates
    serines 112 and 115. This results in conformational change at the C-terminal proline-rich
    binding site for GRB2 (light blue, present in Spry2 only) that now becomes accessible
    and prevents interaction with SOS required for downstream ERK activation (interacting
    proteins indicated in light gray boxes). Other binding partners and covalent modifiers
    (listed in dark gray boxes) have been demonstrated to interact mainly with human
    Spry2. Based on sequence similarities and experimental evidence, however, many
    of them also bind Spry1 and Spry4 [, ]. Spry4 has been shown to inhibit the ERK
    pathway predominantly by interaction with SOS1, and all Sprouties may form functionally
    active hetero- and homo-oligomers through their C-terminal domains []. Src, non-receptor
    kinase; C-Cbl, Casitas b-lineage lymphoma ubiquitin E3 ligase; CIN85, Cbl-interacting
    protein of 85 kD; PLCγ, phospholipase Cγ; SIAH2, seven in absentia homolog ubiquitin
    E3 ligase; PP2A, protein phosphatase 2A; PKC, protein kinase C; Tesk1, testicular
    protein kinase 1; CK, casein kinase; DYRK1A, dual-specificity tyrosine-phosphorylation-regulated
    kinase 1A
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SOS1
  - SOS2
  - SRC
  - SH3KBP1
  - SIAH2
  - DYRK1A
  - FRS2
  - NRAS
  - PRKCG
  - PRKCZ
  - PRKCQ
  - GRB2
  - PRKD3
  - PRKCA
  - PRKCB
  - PRKCI
  - CSNK2A1
  - CSNK2B
  - PLCG1
  - PLCG2
  - RAF1
  - MAPK3
  - MAPK1
  - ARAF
  - BRAF
  - MAP2K1
  - MAP2K2
  - HRAS
  - KRAS
  - PRKCE
  - PRKCH
  - CSNK1A1
  - CSNK2A2
  - TESK1
  - PRKCD
  - SIAH2
genes:
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: CIN85
  symbol: CIN85
  source: hgnc_alias_symbol
  hgnc_symbol: SH3KBP1
  entrez: '30011'
- word: SIAH2
  symbol: SIAH2
  source: hgnc_symbol
  hgnc_symbol: SIAH2
  entrez: '6478'
- word: DYRK1A
  symbol: DYRK1A
  source: hgnc_symbol
  hgnc_symbol: DYRK1A
  entrez: '1859'
- word: FRS2
  symbol: FRS2
  source: hgnc_symbol
  hgnc_symbol: FRS2
  entrez: '10818'
- word: (Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A1
  entrez: '1457'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2B
  entrez: '1460'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: Raf1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Raf/MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf/MEK/ERK
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Raf/MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: (Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: (Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: CK1
  symbol: CK1
  source: hgnc_alias_symbol
  hgnc_symbol: CSNK1A1
  entrez: '1452'
- word: CK2
  symbol: CK2
  source: bioentities_symbol
  hgnc_symbol: CSNK2A2
  entrez: '1459'
- word: Tesk1
  symbol: TESK1
  source: hgnc_symbol
  hgnc_symbol: TESK1
  entrez: '7016'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
chemicals: []
diseases:
- word: SIAH2
  source: ''
  identifier: ''
---
